The study of clinical means of detcting circulating cancer cells on T1b-renal cell carcinoma

The study of clinical means of detcting circulating cancer cells on T1b-renal cell carcinoma - The study of clinical means of detcting circulating cancer cells on T1b-renal cell carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-C000000284

Enrollment

200

Registered

2012-06-01

Start date

2002-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal cell carccinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients who can understand the explanation for obtaining informed consent and who are capable of giving informed consent. 2.Patients who have been informed that they have renal cell carcinoma (RCC) and from whom written informed consent to particiapte in the study has been obtained. 3.Performance Status(JCOG):0-2 4.Age: 20=

Exclusion criteria

Exclusion criteria: 1.Patients with active multiple cancers. 2.Patients received partial nephrectomy or tumor enucleation. 3.Patient of HBV and/or HCV infection. 4.Patients judged inappropriate by the physician.

Design outcomes

Primary

Measure	Time frame
1.Relationship between detection of circulating Cad-6/CA-9 positive cells and clinicopathological factors in renal cell carcinoma. 2.Relationship between detection of circulating Cad-6/CA-9 positive cells and metastasis in renal cell carcinoma. 3.Difference in detection rate of circulation Cad-6 and CA9 positive cells according to surgical approaches.	—

Countries

Japan

Contacts

Public ContactHirotsugu Uemura

Kinki University School of Medicine, Department of Urology

huemura@med.kindai.ac.jp+81723660221

Outcome results